A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001）
Clinical trial NCT05707676 · TERMINATED
Trial details
- NCT number
- NCT05707676
- Sponsor
- L & L Bio Co., Ltd., Ningbo, China
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2024-12-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.